Cargando…

Human prion diseases: progress in clinical trials

Detalles Bibliográficos
Autor principal:	Zerr, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Scientific Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613718/ https://www.ncbi.nlm.nih.gov/pubmed/23550111 http://dx.doi.org/10.1093/brain/awt075

Ejemplares similares

Prion2022-pushing the boundaries
por: Zerr, Inga
Publicado: (2023)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

Prion 2022 Conference abstracts: pushing the boundaries
por: Zerr, Inga
Publicado: (2022)

Prion Peptide Uptake in Microglial Cells – The Effect of Naturally Occurring Autoantibodies against Prion Protein
por: Roettger, Yvonne, et al.
Publicado: (2013)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Mutability of prions
por: Li, Jiali, et al.
Publicado: (2011)

Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease
por: Cheng, Lesley, et al.
Publicado: (2021)

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
por: Shafiq, Mohsin, et al.
Publicado: (2021)

Of Viroids and Prions
por: Diener, Theodor O.
Publicado: (2018)

Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay
por: Sano, Kazunori, et al.
Publicado: (2013)

Classifying prion and prion-like phenomena
por: Harbi, Djamel, et al.
Publicado: (2014)

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
por: Kanata, Eirini, et al.
Publicado: (2018)

Primary progressive aphasia: in search of brief cognitive assessments
por: Matias-Guiu, Jordi A, et al.
Publicado: (2022)

Towards a more cognitive evaluation of progressive aphasias?
por: Renard, Antoine, et al.
Publicado: (2022)

Cellular Prion Protein (PrP(c)) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in Health
por: Ramljak, Sanja, et al.
Publicado: (2016)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Virtual drug screening for prion diseases: A valuable step?
por: Cordeiro, Yraima
Publicado: (2016)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

SARS-CoV-2 Invasion and Pathological Links to Prion Disease
por: Lukiw, Walter J., et al.
Publicado: (2022)

The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
por: Eraña, Hasier
Publicado: (2019)

Multifocal hits for propagation of prion protein in sporadic Creutzfeldt-Jakob disease
por: Kasuga, Kensaku, et al.
Publicado: (2014)

Analysis of 22 Years of Surveillance for Prion Diseases in Slovenia, 1996 to 2017
por: čakš Jager, Nuška, et al.
Publicado: (2018)

Alzheimer’s disease, cerebrovascular disease and dementia: lump, split or integrate?
por: Biessels, Geert Jan
Publicado: (2022)

Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells
por: Zafar, Saima, et al.
Publicado: (2017)

Theoretically meaningful models can answer clinically relevant questions
por: Evans, Nathan J, et al.
Publicado: (2019)

Dangerous Liaisons between a Microbe and the Prion Protein
por: Aguzzi, Adriano, et al.
Publicado: (2003)

Lesion-network mapping for tics: moving from replication to clinical translation
por: Ganos, Christos, et al.
Publicado: (2023)

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
por: Zerr, Inga, et al.
Publicado: (2019)

Music, memory and mechanisms in Alzheimer’s disease
por: Clark, Camilla N., et al.
Publicado: (2015)

New hope for devastating neurodegenerative disease
por: Stayte, Sandy, et al.
Publicado: (2017)

BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
por: López-Pérez, Óscar, et al.
Publicado: (2020)

Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice
por: Ramljak, Sanja, et al.
Publicado: (2021)

Concatenating plasma p-tau to Alzheimer’s disease
por: Tijms, Betty M, et al.
Publicado: (2021)

Strengthening the link between mitophagy and Parkinson’s disease
por: Ganley, Ian G
Publicado: (2022)

Quantitative postural models as biomarkers of balance in Parkinson’s disease
por: Xiang, Min, et al.
Publicado: (2018)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Detecting early changes in Alzheimer’s disease with graph theory
por: Pereira, Joana B
Publicado: (2020)

Mirolysin structures open a window on gum disease
por: Radisky, Evette S.
Publicado: (2020)

Dying-back of ascending noradrenergic projections in Parkinson’s disease
por: Helmich, Rick C, et al.
Publicado: (2021)

Human stem cell-derived ventral midbrain astrocytes exhibit a region-specific secretory profile
por: Crompton, Lucy A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_598p7fj6pb0hidagpdf7ossa2s